Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pfizer
(NY:
PFE
)
25.40
+0.14 (+0.55%)
Official Closing Price
Updated: 7:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
Today 14:45 EDT
Acuitas Therapeutics settles lawsuit with CureVac over COVID-19 vaccine patents. Legal disputes unfold among biotech giants Pfizer, BioNTech, and CureVac, as GSK joins the fray, alleging patent...
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
COVID-19
Financial
Intellectual Property
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Today 14:30 EDT
FDA approves Pfizer's Beqvez for adults with hemophilia B, offering a one-time treatment to produce FIX. Experience reduced bleeding frequency. Explore Pfizer's warranty program.
Via
Benzinga
Exposures
Product Safety
Pfizer's Options: A Look at What the Big Money is Thinking
Today 10:02 EDT
Via
Benzinga
Want $2,000 in Annual Dividends? Invest $30,000 in These 3 Stocks
Today 7:45 EDT
Put your money to work by investing in these three high-quality dividend stocks.
Via
The Motley Fool
Pfizer Now Rivals The World's Most Expensive Medicine After FDA Approves Gene Therapy
Today 6:46 EDT
Pfizer won FDA approval for a new hemophilia B gene therapy, a rival to Hemgenix from CSL and Uniqure.
Via
Investor's Business Daily
Exposures
Product Safety
Creative Biolabs: The Way ADCs Are Made Has Changed
April 23, 2024
Via
Get News
US Stock: Pfizer
April 23, 2024
Pfizer is engaged in the discovery, development, manufacture, marketing, sale, and distribution of biopharmaceutical products worldwide.
Via
Talk Markets
Pfizer Options Trading: A Deep Dive into Market Sentiment
April 22, 2024
Via
Benzinga
U.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia B
Today 6:45 EDT
From
Pfizer Inc.
Via
Business Wire
What's Going On With Pfizer Stock On Thursday?
April 25, 2024
GSK initiates legal proceedings against Pfizer and BioNTech over alleged COVID-19 vaccine patent infringement, intensifying high-stakes legal battles in the U.S.
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
3 Bargain Stocks Near 52-week Lows
April 25, 2024
Three undeniable bargains came into play after the market's disappointment sell off, investors still have double-digit upside ahead of them in these names
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
April 25, 2024
The radiopharmaceuticals space could be worth up to $25 billion, according to one estimate.
Via
Investor's Business Daily
Pfizer Inc. (NYSE: PFE) Near Top of Volume Charts in Wednesday Trading
April 17, 2024
Via
Investor Brand Network
Exposures
COVID-19
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
April 25, 2024
Via
Benzinga
Pfizer Declares Second-Quarter 2024 Dividend
April 24, 2024
From
Pfizer Inc.
Via
Business Wire
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
April 24, 2024
Discover the top dividend stocks for prolonged wealth in 2024 in pharmaceuticals, integrated telecommunications, drug retail, and tobacco.
Via
InvestorPlace
3 Speculative Weight Loss Drug Stocks to Bet On for Big Gains
April 24, 2024
These weight loss drug stocks are relatively unknown and brimming with potential following the massive success of Novo Nordisk and Eli Lilly.
Via
InvestorPlace
3 Defensive Stocks To Protect Your Portfolio In 2024
April 23, 2024
Alcohol, tobacco, and drugs as bulwarks against market shocks, and these three stocks are now trading under low ballparks.
Via
Talk Markets
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown
April 23, 2024
Moderna challenges Pfizer and BioNTech in a London patent trial over mRNA vaccine patents. The outcome may reshape the pharmaceutical landscape, impacting future innovations and revenue streams.
Via
Benzinga
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
3 Underappreciated Pharmaceutical Stocks to Buy Before They Surge
April 23, 2024
These are the undervalued pharmaceutical stocks to buy as they have a deep clinical pipeline which will driven earnings and cash flow growth.
Via
InvestorPlace
Better Buy: Pfizer vs. Viking Therapeutics
April 23, 2024
These two pharma stocks have followed distinct paths of late. Which is the better investment?
Via
The Motley Fool
1 No-Brainer Vanguard Fund to Buy Right Now
April 23, 2024
This Vanguard growth fund is home to some of the world's most innovative companies.
Via
The Motley Fool
3 Blue-Chip Stocks That Will Beat Index Returns Over the Next 3 Years
April 22, 2024
These are the undervalued blue-chip stocks to buy as they represent fundamentally strong ideas poised for accelerated growth.
Via
InvestorPlace
European Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment Options
April 22, 2024
From
Pfizer Inc.
Via
Business Wire
Capturing Consumer Spending on Health Care with XLV
April 22, 2024
Capturing Consumer Spending on Health Care with XLV
Via
News Direct
3 Stocks Under $50 You Can Buy Hand Over Fist Right Now
April 20, 2024
A little up-front investment can go a long way with these three stocks.
Via
The Motley Fool
If You'd Invested $1,000 in Pfizer 5 Years Ago, Here's How Much You'd Have Today
April 18, 2024
The answer to that question will either make you wince or smile.
Via
The Motley Fool
The 3 Most Overlooked Stocks Set for a Triple-Digit Comeback
April 17, 2024
Learn how these overlooked stocks are set for a massive resurgence with leads in pharmaceutical, broadline retail and interactive media.
Via
InvestorPlace
3 No-Brainer Stocks to Buy With $100 Right Now
April 17, 2024
A modest amount of money can go a long way in the stock market when it's put to work in time-tested businesses with well-defined competitive advantages.
Via
The Motley Fool
Johnson & Johnson Shows Focus On Strengthening Its Business Upon Its Consumer Health Unit Spinoff
April 16, 2024
On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates as sales in its medical devices business surged, while revenue was almost...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.